Access Mobile Health Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 60021 Monroe St, Smithville, MS 38870 Phone: 662-651-4637 |
Access Family Health - Smithville Clinic Clinic/Center - Community Health Medicare: Medicare Enrolled Practice Location: 60021 Monroe St, Smithville, MS 38870 Phone: 662-651-4637 Fax: 662-651-4636 |
Access Family Dental Clinic Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 60024 Olive St, Smithville, MS 38870 Phone: 662-651-7111 Fax: 662-651-7115 |
Access School Health - Smithville Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 60017 Highway 23, Smithville, MS 38870 Phone: 662-651-4276 Fax: 662-651-4163 |
News Archive
Higher coronary artery calcium levels in middle-age were associated with structural heart abnormalities linked to future heart failure, particularly among blacks, according to new research in Circulation: Cardiovascular Imaging, an American Heart Association journal.
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want.
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.
Escherichia coli - E. coli for short - is often identified as a bacterium that contributes to foodborne illness. But research led by a Rice University scientist has discovered ways to use a safe, non-pathogenic E. coli to convert glycerine into high value fuels and chemicals.
Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. have announced that the U.S. Federal Trade Commission ("FTC") has accepted the proposed consent order in connection with the pending acquisition of Barr by Teva and granted early termination of the Hart Scott Rodino waiting period.
› Verified 4 days ago